Literature DB >> 741533

Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.

P Perlmann, M Troye, G Pape, H Blomgren, B Johansson.   

Abstract

The cytoxicity in vitro fo peripheral blood lymphocytes from patients with carcinoma of the urinary bladder (TCC-bladder) against allogeneic target cells from established cell lines was studied by the 51Cr-release assay. Lymphocytes from both untreated and treated TCC-bladder patients have a significantly elevated mean cytotoxicity to TCC-bladder target cells. Tumour cell destruction by lymphocytes from TCC-bladder patients shows a clear disease related specificity. In TCC-bladder patients a superimposed cytotoxicity exists, probably reflecting reactions against one or several tumour - associated antigens. In treated patients this cytotoxicity may be masked by higher incidence of cross reaction.

Entities:  

Mesh:

Year:  1978        PMID: 741533     DOI: 10.1007/bf00262619

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  12 in total

1.  In vitro assays of cell-mediated immunity to human solid tumors: problems of quantitation, specificity, and interpretation.

Authors:  R W Baldwin
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

2.  Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays.

Authors:  R B Herberman; R K Oldham
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

3.  Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay.

Authors:  M Troye; P Perlmann; A Larsson; H Blomgren; B Johansson
Journal:  Int J Cancer       Date:  1977-08-15       Impact factor: 7.396

4.  Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.

Authors:  M A Bean; H Pees; J E FOGH; H Grabstald; H F Oettgen
Journal:  Int J Cancer       Date:  1974-08-15       Impact factor: 7.396

5.  Immune response to urinary bladder tumours in man.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-01-15       Impact factor: 7.396

6.  A microassay for cell-mediated immunity.

Authors:  M Takasugi; E Klein
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

7.  Cellular and humoral immune responses to human urinary bladder carcinomas.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-05-15       Impact factor: 7.396

8.  The use of Fab fragments of anti-human immunoglobulin as analytic tools for establishing the involvement of immunoglobulin in the spontaneous cytotoxicity to cultured tumor cells by lymphocytes from patients with bladder carcinoma and from healthy donors.

Authors:  M Troye; P Perlmann; G R Pape; H L Spiegelberg; I Näslund; A Gidlöf
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

9.  Assessment of cell-mediated immunity to human tumor-associated antigens.

Authors:  R W Baldwin; M J Embeton
Journal:  Int Rev Exp Pathol       Date:  1977

10.  Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture.

Authors:  G R Pape; M Troye; P Perlmann
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

View more
  1 in total

1.  Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trial.

Authors:  H Blomgren; I Näslund; P L Esposti; L Johansen; O Aaskoven
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.